These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39314017)

  • 1. S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 1: Diagnosis, initial management, and immunomodulating systemic therapy.
    Heuer R; Paulmann M; Annecke T; Behr B; Boch K; Boos AM; Brockow K; French LE; Gille J; Gundlach V; Hartmann B; Höger P; Hofmann SC; Klein T; Lehnhardt M; Liß Y; Maier P; Mandel P; Marathovouniotis N; Marlok F; Mittelviefhaus H; Pleyer U; Pradeau M; Rall K; Rieg S; Rittner H; Sander F; Schnitzler S; Schut C; Stolle A; Vorobyev A; Wedi B; Weiss J; Zepp M; Ziemer M; Mockenhaupt M; Nast A
    J Dtsch Dermatol Ges; 2024 Oct; 22(10):1448-1466. PubMed ID: 39314017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 2: Supportive therapy of EN in the acute and post-acute stages.
    Paulmann M; Heuer R; Annecke T; Behr B; Boch K; Boos AM; Brockow K; French LE; Gille J; Gundlach V; Hartmann B; Höger P; Hofmann SC; Klein T; Lehnhardt M; Liß Y; Maier P; Mandel P; Marathovouniotis N; Marlok F; Mittelviefhaus H; Pleyer U; Pradeau M; Rall K; Rieg S; Rittner H; Sander F; Schnitzler S; Schut C; Stolle A; Vorobyev A; Wedi B; Weiss J; Zepp M; Ziemer M; Mockenhaupt M; Nast A
    J Dtsch Dermatol Ges; 2024 Nov; 22(11):1576-1593. PubMed ID: 39417754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.
    Zimmermann S; Sekula P; Venhoff M; Motschall E; Knaus J; Schumacher M; Mockenhaupt M
    JAMA Dermatol; 2017 Jun; 153(6):514-522. PubMed ID: 28329382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
    Creamer D; Walsh SA; Dziewulski P; Exton LS; Lee HY; Dart JKG; Setterfield J; Bunker CB; Ardern-Jones MR; Watson KMT; Wong GAE; Philippidou M; Vercueil A; Martin RV; Williams G; Shah M; Brown D; Williams P; Mohd Mustapa MF; Smith CH
    J Plast Reconstr Aesthet Surg; 2016 Jun; 69(6):e119-e153. PubMed ID: 27287213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.
    Seminario-Vidal L; Kroshinsky D; Malachowski SJ; Sun J; Markova A; Beachkofsky TM; Kaffenberger BH; Ergen EN; Mauskar M; Bridges A; Calhoun C; Cardones AR; Chen ST; Chodosh J; Cotliar J; Davis MDP; DeNiro KL; Dominguez AR; Eljure-Téllez J; Femia A; Fox LP; Guda A; Mitchell C; Mostaghimi A; Ortega-Loayza AG; Owen C; Pasieka H; Rahnama-Moghadam S; Saeed HN; Saunderson RB; Shanbhag S; Sharon VR; Strowd L; Venkatesh S; Wanat KA; Wetter DA; Worswick S; Micheletti RG
    J Am Acad Dermatol; 2020 Jun; 82(6):1553-1567. PubMed ID: 32151629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
    Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
    Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Antoon JW; Goldman JL; Lee B; Schwartz A
    Pediatr Dermatol; 2018 Mar; 35(2):182-187. PubMed ID: 29315761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.
    Ramien ML; Mansour D; Shear NH
    Paediatr Drugs; 2022 Jul; 24(4):307-319. PubMed ID: 35676614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis - diagnosis and treatment.
    Grünwald P; Mockenhaupt M; Panzer R; Emmert S
    J Dtsch Dermatol Ges; 2020 Jun; 18(6):547-553. PubMed ID: 32469468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High risk and low prevalence diseases: Stevens Johnson syndrome and toxic epidermal necrolysis.
    van Nispen C; Long B; Koyfman A
    Am J Emerg Med; 2024 Jul; 81():16-22. PubMed ID: 38631147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins).
    Ingen-Housz-Oro S; Duong TA; Bensaid B; Bellon N; de Prost N; Lu D; Lebrun-Vignes B; Gueudry J; Bequignon E; Zaghbib K; Royer G; Colin A; Do-Pham G; Bodemer C; Ortonne N; Barbaud A; Fardet L; Chosidow O; Wolkenstein P;
    Orphanet J Rare Dis; 2018 Apr; 13(1):56. PubMed ID: 29636107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-johnson Syndrome and Toxic Epidermal Necrolysis: An Overview of Diagnosis, Therapy Options and Prognosis of Patients.
    Garg VK; Buttar HS; Bhat SA; Ainur N; Priya T; Kashyap D; Tuli HS
    Recent Adv Inflamm Allergy Drug Discov; 2023; 17(2):110-120. PubMed ID: 37605396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burn unit care of Stevens Johnson syndrome/toxic epidermal necrolysis: A survey.
    Le HG; Saeed H; Mantagos IS; Mitchell CM; Goverman J; Chodosh J
    Burns; 2016 Jun; 42(4):830-5. PubMed ID: 26810444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe drug-induced skin reactions. Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Mockenhaupt M
    Hautarzt; 2014 May; 65(5):415-23. PubMed ID: 24820799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis--A Comprehensive Review and Guide to Therapy. I. Systemic Disease.
    Kohanim S; Palioura S; Saeed HN; Akpek EK; Amescua G; Basu S; Blomquist PH; Bouchard CS; Dart JK; Gai X; Gomes JA; Gregory DG; Iyer G; Jacobs DS; Johnson AJ; Kinoshita S; Mantagos IS; Mehta JS; Perez VL; Pflugfelder SC; Sangwan VS; Sippel KC; Sotozono C; Srinivasan B; Tan DT; Tandon R; Tseng SC; Ueta M; Chodosh J
    Ocul Surf; 2016 Jan; 14(1):2-19. PubMed ID: 26549248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.